187 related articles for article (PubMed ID: 14586409)
1. Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.
Moore L; Venkatachalam S; Vogel H; Watt JC; Wu CL; Steinman H; Jones SN; Donehower LA
Oncogene; 2003 Oct; 22(49):7831-7. PubMed ID: 14586409
[TBL] [Abstract][Full Text] [Related]
2. Loss of p19ARF enhances the defects of Mdm2 overexpression in the mammary gland.
Foster CJ; Lozano G
Oncogene; 2002 May; 21(22):3525-31. PubMed ID: 12032854
[TBL] [Abstract][Full Text] [Related]
3. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
5. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
6. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts.
Kurokawa K; Tanaka T; Kato J
Oncogene; 1999 Apr; 18(17):2718-27. PubMed ID: 10348346
[TBL] [Abstract][Full Text] [Related]
7. p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.
Khan S; Guevara C; Fujii G; Parry D
Oncogene; 2004 Aug; 23(36):6040-6. PubMed ID: 15195142
[TBL] [Abstract][Full Text] [Related]
8. Tumor spectrum in ARF-deficient mice.
Kamijo T; Bodner S; van de Kamp E; Randle DH; Sherr CJ
Cancer Res; 1999 May; 59(9):2217-22. PubMed ID: 10232611
[TBL] [Abstract][Full Text] [Related]
9. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
10. Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis.
Matsuoka M; Kurita M; Sudo H; Mizumoto K; Nishimoto I; Ogata E
Biochem Biophys Res Commun; 2003 Feb; 301(4):1000-10. PubMed ID: 12589812
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
[TBL] [Abstract][Full Text] [Related]
12. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
[TBL] [Abstract][Full Text] [Related]
13. p53-independent functions of the p19(ARF) tumor suppressor.
Weber JD; Jeffers JR; Rehg JE; Randle DH; Lozano G; Roussel MF; Sherr CJ; Zambetti GP
Genes Dev; 2000 Sep; 14(18):2358-65. PubMed ID: 10995391
[TBL] [Abstract][Full Text] [Related]
14. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
[TBL] [Abstract][Full Text] [Related]
16. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
Tago K; Chiocca S; Sherr CJ
Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
[TBL] [Abstract][Full Text] [Related]
17. Expression of p14ARF overcomes tumor resistance to p53.
Lu W; Lin J; Chen J
Cancer Res; 2002 Mar; 62(5):1305-10. PubMed ID: 11888896
[TBL] [Abstract][Full Text] [Related]
18. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.
Ries S; Biederer C; Woods D; Shifman O; Shirasawa S; Sasazuki T; McMahon M; Oren M; McCormick F
Cell; 2000 Oct; 103(2):321-30. PubMed ID: 11057904
[TBL] [Abstract][Full Text] [Related]
19. Decreased Mdm2 expression inhibits tumor development and extends survival independent of Arf and dependent on p53.
Eischen CM; Boyd K
PLoS One; 2012; 7(9):e46148. PubMed ID: 23029416
[TBL] [Abstract][Full Text] [Related]
20. Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.
O'Leary KA; Mendrysa SM; Vaccaro A; Perry ME
Mol Cell Biol; 2004 Jan; 24(1):186-91. PubMed ID: 14673154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
